
TriSalus Life Sciences Hits New 52-Week High at $5.95
2025-11-25 16:26:22TriSalus Life Sciences, Inc. has achieved a new 52-week high of USD 5.95, marking a significant milestone for the microcap company in the Pharmaceuticals & Biotechnology sector. Despite a 1-year performance decline, it maintains a market capitalization of approximately USD 250 million and a notable return on equity of 184.33%.
Read MoreIs TriSalus Life Sciences, Inc. technically bullish or bearish?
2025-09-20 20:26:37As of 18 August 2025, the technical trend for TriSalus Life Sciences, Inc. has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD also shows mildly bullish. However, the daily moving averages are mildly bearish, and the Bollinger Bands on a monthly basis are bearish. The KST presents a mixed view with a weekly bearish signal and a mildly bullish monthly signal. Overall, there is no clear trend indicated by Dow Theory or OBV. In terms of performance, TriSalus has underperformed compared to the S&P 500 across multiple periods, with a year-to-date return of -1.8% versus the S&P 500's 12.22%, and a one-year return of 6.49% compared to 17.14%. This suggests a weaker technical stance despite some mildly bullish indicators....
Read More





